Unchained Labs

Pleasanton, United States Founded: 2015 • Age: 11 yrs Acquired By The Carlyle Group
Multiplex protein stability platform for biologics is developed.

About Unchained Labs

Unchained Labs is a Healthcare company based in Pleasanton (United States) founded in 2015 by Tim Harkness, and was acquired by The Carlyle Group in April 2021. Multiplex protein stability platform for biologics is developed. Unchained Labs has raised $111 million across 7 funding rounds from investors including SVB, Golub Capital and The Carlyle Group. Unchained Labs has completed 6 acquisitions, including AVIA Biosystems, Blacktrace and Freeslate. Its chief executive, as recorded, is Tim Harkness. Its website unchainedlabs.com draws about 27 thousand monthly visits. Unchained Labs offers products and services including Aunty, Stunner, Honeybun, Unagi, and Leprechaun. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified. Its competitors include Cepheid, Beckman Coulter and Blackrock Neurotech; 2 of its 3 listed competitors have raised funding.

Company details

Unchained Labs was founded in 2015 in Pleasanton, United States, within the biotechnology sector. A multiplex platform called Optim is provided for assessing protein stability in biologics, where parameters such as denaturing temperature and aggregation onset are measured across multiple samples. Applications include lead candidate selection, optimization, pre-formulation studies, formulation development, and ongoing stability evaluations for research purposes.

Key Metrics
  • Total Equity Funding
    $111M (USD)

    in 7 rounds

  • Latest Funding Round
    $155M (USD), Debt – Conventional

    Aug 2021

  • Investors
    SVB

    & 7 more

  • Investments & Acquisitions
  • Acquired by

Products & Services of Unchained Labs

Unchained Labs offers a comprehensive portfolio of products and services, including Aunty, Stunner, Honeybun, Unagi, and Leprechaun.

Aunty
Stability Tool

High-throughput tool for protein stability characterization in biologics.

Stunner
Quantification Tool

Device for quantification and sizing of biologics and gene therapy samples.

Honeybun
Viscosity Tool

Rapid viscometer for measuring viscosity in scientific formulations.

Unagi
Buffer Exchange Tool

Automated system for buffer exchange and sample preparation workflows.

Leprechaun
Characterization Tool

Instrument for lentivirus and exosome characterization in cell therapy.

Sunscreen
Formulation Tool

Automated screener for LNP formulation optimization processes.

Apps and channels of Unchained Labs

its YouTube channel Unchained Labs has 804 subscribers and 30 videos.

Unchained Labs
YouTube 804 subscribers 30 videos Science & Technology
Open channel

Videos from Unchained Labs

The most watched videos on Unchained Labs's YouTube channel, Unchained Labs (804 subscribers). Click a video to play it here.

Virtual Seminar: Make light work of liposomal development and optimization with Sunshine
1.2K views
Unchained Tackles Science in 5: ADC Characterization with Stunner
838 views
Unchained Tackles Science in 5: LNP formulation screening with Sunscreen
496 views
Unchained Labs Tackles Science in 5: High-Throughput Protein Stability with Aunty
463 views

More on Unchained Labs.

Funding Insights of Unchained Labs

Unchained Labs has successfully raised a total of $111M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $155 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $111M
  • Total Rounds 7
  • Last Round Debt – Conventional β€” $155M
  • First Round $25M

    (Feb 2015)

  • Investors Count 7

All 7 funding rounds of Unchained Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2021$155MDebt – Conventional––
May 2019$50MDebt – Conventional––
Mar 2018$17MSeries D–Tri-Valley Ventures
Jun 2017$13MSeries C–Canaan, Novo Holdings
–
Feb 2016$25MSeries B––
–
Jun 2015$31MSeries B–Canaan, Novo Holdings
–
Feb 2015$25MSeries A––
–
Valuation history

8 investors in total: 8 institutional.

Investors in Unchained Labs

Unchained Labs has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Golub Capital and The Carlyle Group.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private debt funds are managed across multiple sectors.
2008midcapfinancial.comBethesda, United States
Private equity and venture capital fund focused on the healthcare sector
novoholdings.dkHellerup, Denmark
Canaan is recognized as an early-stage venture capital firm.
1987canaan.comSan Francisco, United States
Fund of funds focused on pre-seed and seed-stage companies
1992tpg.comFort Worth, United States
VC funds investing in technology startups
trivalleyventures.comPleasanton, United States
Private equity investments are directed toward multiple sectors.
1986carlyle.com
Private debt investments are managed for U.S. middle market companies.
1994golubcapital.comChicago, United States
Banking services are provided to innovative companies, investors, and individuals.
1983svb.comSanta Clara, United States
Premium access

Investor details for Unchained Labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Unchained Labs

53 people are tracked at Unchained Labs (17 in leadership, 4 in board & advisors, 32 in team).

NameRoleGroup
Tim Harkness
Founder & CEOLeadership
Dustin Giberson
VP, OperationsLeadership
Don Phelps
VP, FinanceLeadership
Tomoo Shinya
General Manager JapanLeadership
Brigitte Comrie
Director Of QualityLeadership
Martha Perez
Director Emerging MarketsLeadership
Mike Nersesian
Sr Director OperationsLeadership
David Wyrick
VP Of Product DevelopmentLeadership
Peter Luk
Vice President Of Commercial, Asia PacificLeadership
Theresa Harper
Senior Director, Workflows OperationsLeadership
Kris Naessens
Senior Director OperationsLeadership
Andrew Malloy
VP Of Biologics And Gene Therapy EMEALeadership
Krystin Schmidt
VP MarketingLeadership
Kevin Lance
Director Of Viral Vector MarketingLeadership
Richard Goldhoff
Director Sales & Marketing OperationsLeadership
Christie Lau
Human Resources DirectorLeadership
Lucas Treffkorn
Director Of ManufacturingLeadership
Samuel Tang
Board MemberBoard & advisors
Martin D. Madaus
Board MemberBoard & advisors
Robert R. Schmidt
Board MemberBoard & advisors

33 more people are available in the full profile.

Premium access

Complete people profiles for Unchained Labs

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Unchained Labs

Unchained Labs has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include AVIA Biosystems, Blacktrace and Freeslate.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Designer, developer, and manufacturer of microfluidic products, precision glass fabrication, and microstructured materials
blacktrace.comRoyston, United Kingdom2001Jul 2023β€’β€’β€’β€’
Nanotechnology-based platform for single biomolecule detection is provided.
nanoviewbio.comBoston, United States2015May 2022β€’β€’β€’β€’
Contract-based biopharmaceutical development and quality control services are provided.
rap-id.comBerlin, Germany2002Mar 2018β€’β€’β€’β€’
UV/VIS spectrometry solutions for biomolecular analysis are provided.
trinean.comGentbrugge, Belgium2006Jun 2017β€’β€’β€’β€’
High-throughput automation products for research are provided by Freeslate.
freeslate.comPleasanton, United States2010Feb 2016β€’β€’β€’β€’
Isothermal Chemical Denaturation (ICD) system for measuring biologic stability
aviabiosystems.comNorton, United States2012Jun 2015β€’β€’β€’β€’
Premium access

Complete acquisition details for Unchained Labs

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Unchained Labs

10 dated milestones of Unchained Labs across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Unchained Labs is founded.
  2. Funding First funding round of $25.0M.
  3. Acquisition Acquires AVIA Biosystems.
  4. Acquisition Acquires Freeslate.
  5. Acquisition Acquires Trinean.
  6. Acquisition Acquires Rap.ID.
  7. Exit Acquired by The Carlyle Group.
  8. Funding Latest funding round, Debt – Conventional, of $155.0M.
  9. Acquisition Acquires NanoView Biosciences.
  10. Acquisition Acquires Blacktrace.

Competitors of Unchained Labs

Unchained Labs has 3 listed competitors in our database, 2 of them funded. They include Cepheid, Beckman Coulter and Blackrock Neurotech.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
beckman.com1935Brea, United States
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
blackrockneurotech.com2008Salt Lake, United States$22.37M127
Medical devices for neurological therapies are developed.
Premium access

Detailed competitors of Unchained Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Unchained Labs

The website of Unchained Labs (unchainedlabs.com) receives about 26.8K visits a month.

  • Monthly visits
    26.8K

    ▼ 17.7% vs previous month

Similar websites

Websites whose visitors overlap most with Unchained Labs. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lambda-instruments.com
100%
View details
fluentbio.com
98%
4.7K#3,913,179View details
biolabs.io
94%
#967,548View details
cusabio.com
85%
#252,380View details
asimov.com
85%
61.3K#647,285View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 23 similar websites and full traffic analytics for Unchained Labs

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 23 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Unchained Labs (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Unchained Labs

Premium access

Complete news archive for Unchained Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Unchained Labs

Unchained Labs was founded in 2015.

Unchained Labs is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.

Tim Harkness is the CEO of Unchained Labs, as recorded in our data. They have also founded this company.

Unchained Labs is a funded company, having raised a total of $111M across 7 funding rounds to date. The company's 1st funding round was a Series A of $25M, raised on Feb 2015.

Unchained Labs was founded in 2015 in Pleasanton, United States, within the biotechnology sector. A multiplex platform called Optim is provided for assessing protein stability in biologics, where parameters such as denaturing temperature and aggregation onset are measured across multiple samples. Applications include lead candidate selection, optimization, pre-formulation studies, formulation development, and ongoing stability evaluations for research purposes.

Unchained Labs's top competitors include Cepheid, Blackrock Neurotech and Beckman Coulter.

Unchained Labs offers Aunty, Stunner, Honeybun, Unagi, and 2 more products and services.

Unchained Labs has made 6 acquisitions, including AVIA Biosystems, Blacktrace, and Freeslate.

Unchained Labs has 8 investors. Key investors include SVB, Golub Capital, The Carlyle Group, TPG, and MidCap Financial.

Yes. Unchained Labs was acquired by The Carlyle Group in April 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available